Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors.
Journal
Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
16
07
2021
accepted:
22
02
2022
revised:
01
02
2022
pubmed:
20
3
2022
medline:
31
5
2022
entrez:
19
3
2022
Statut:
ppublish
Résumé
In one of the largest, most comprehensive studies on borderline personality disorder (BPD) to date, this article places into context associations between this diagnosis and (1) 16 different psychiatric disorders, (2) eight somatic illnesses, and (3) six trauma and adverse behaviors, e.g., violent crime victimization and self-harm. Second, it examines the sex differences in individuals with BPD and their siblings. A total of 1,969,839 Swedish individuals were identified from national registers. Cumulative incidence with 95% confidence intervals (CI) was evaluated after 5 years of follow-up from BPD diagnosis and compared with a matched cohort. Associations were estimated as hazard ratios (HR) with 95% CIs from Cox regression. 12,175 individuals were diagnosed with BPD (85.3% female). Individuals diagnosed with BPD had higher cumulative incidences and HRs for nearly all analyzed indicators, especially psychiatric disorders. Anxiety disorders were most common (cumulative incidence 95% CI 33.13% [31.48-34.73]). Other notable findings from Cox regressions include psychotic disorders (HR 95% CI 24.48 [23.14-25.90]), epilepsy (3.38 [3.08-3.70]), violent crime victimization (7.65 [7.25-8.06]), and self-harm (17.72 [17.27-18.19]). HRs in males and females with BPD had overlapping CIs for nearly all indicators. This indicates that a BPD diagnosis is a marker of vulnerability for negative events and poor physical and mental health similarly for both males and females. Having a sibling with BPD was associated with an increased risk for psychiatric disorders, trauma, and adverse behaviors but not somatic disorders. Clinical implications include the need for increased support for patients with BPD navigating the health care system.
Identifiants
pubmed: 35304564
doi: 10.1038/s41380-022-01503-z
pii: 10.1038/s41380-022-01503-z
pmc: PMC9135625
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2514-2521Subventions
Organisme : NIMH NIH HHS
ID : R01 MH123724
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
Gunderson JG, Herpertz SC, Skodol AE, Torgersen S, Zanarini MC. Borderline personality disorder. Nat Rev Dis Prim. 2018;4:1–20.
APA. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Association Publication; 2013.
Frankenburg FR, Zanarini MC. The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry. 2004.
Arola R, Antila H, Riipinen P, Hakko H, Riala K, Kantojärvi L. Borderline personality disorder associates with violent criminality in women: a population based follow-up study of adolescent psychiatric inpatients in Northern Finland. Forensic Sci Int. 2016;266:389–95.
pubmed: 27399875
doi: 10.1016/j.forsciint.2016.06.028
Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004;161:2108–14.
pubmed: 15514413
doi: 10.1176/appi.ajp.161.11.2108
Czajkowski N, Aggen SH, Krueger RF, Kendler KS, Neale MC, Knudsen GP, et al. A twin study of normative personality and DSM-IV personality disorder criterion counts: evidence for separate genetic influences. Am J Psychiatry. 2018;175:649–56.
pubmed: 29558815
pmcid: 6028291
doi: 10.1176/appi.ajp.2017.17050493
Torgersen S, Czajkowski N, Jacobson K, Reichborn-Kjennerud T, Røysamb E, Neale M, et al. Dimensional representations of DSM-IV cluster B personality disorders in a population-based sample of Norwegian twins: a multivariate study. Psychol Med. 2008;38:1617–25.
pubmed: 18275631
doi: 10.1017/S0033291708002924
Skoglund C, Tiger A, Rück C, Petrovic P, Asherson P, Hellner C, et al. Familial risk and heritability of diagnosed borderline personality disorder: a register study of the Swedish population. Mol. Psychiatry. 2019:1–10.
Zapolski TC, Settles RE, Cyders MA, Smith GT. Borderline personality disorder, bulimia nervosa, antisocial personality disorder, ADHD, substance use: common threads, common treatment needs, and the nature of impulsivity. Independent. Practitioner. 2010;30:20.
Tomko RL, Trull TJ, Wood PK, Sher KJ. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Personal Disord. 2014;28:734–50.
doi: 10.1521/pedi_2012_26_093
Welander-Vatn A, Ystrom E, Tambs K, Neale M, Kendler K, Reichborn-Kjennerud T, et al. The relationship between anxiety disorders and dimensional representations of DSM-IV personality disorders: a co-twin control study. J Affect Disord. 2016;190:349–56.
pubmed: 26544619
doi: 10.1016/j.jad.2015.09.038
Barnow S, Arens EA, Sieswerda S, Dinu-Biringer R, Spitzer C, Lang S. Borderline personality disorder and psychosis: a review. Curr Psychiatry Rep. 2010;12:186–95.
pubmed: 20425279
doi: 10.1007/s11920-010-0107-9
Doering S. Borderline personality disorder in patients with medical illness: a review of assessment, prevalence, and treatment options. Psychosom Med. 2019;81:584–94.
pubmed: 31232916
doi: 10.1097/PSY.0000000000000724
Østby KA, Czajkowski N, Knudsen GP, Ystrom E, Gjerde LC, Kendler KS, et al. Personality disorders are important risk factors for disability pensioning. Soc Psychiatry Psychiatr Epidemiol. 2014;49:2003–11.
pubmed: 24791656
pmcid: 4218874
doi: 10.1007/s00127-014-0878-0
El-Gabalawy R, Katz LY, Sareen J. Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosom Med. 2010;72:641–7.
pubmed: 20508177
doi: 10.1097/PSY.0b013e3181e10c7b
Sharma TR. Polycystic ovarian syndrome and borderline personality disorder: 3 case reports and scientific review of literature. J Psychiatry. 2015;18:1–4.
doi: 10.4172/2378-5756.1000336
De Genna NM, Feske U, Larkby C, Angiolieri T, Gold MAPregnancies. abortions, and births among women with and without borderline personality disorder. Women’s Health Issues. 2012;22:e371–e377.
pubmed: 22749198
pmcid: 3397795
doi: 10.1016/j.whi.2012.05.002
Sansone RA, Sansone LA. Borderline personality: a primary care context. Psychiatry. 2004;1:19.
pubmed: 21197375
pmcid: 3012616
de Aquino Ferreira LF, Pereira FHQ, Benevides AMLN, Melo MCA. Borderline personality disorder and sexual abuse: a systematic review. Psychiatry Res. 2018;262:70–77.
pubmed: 29407572
doi: 10.1016/j.psychres.2018.01.043
Conway CC, Boudreaux M, Oltmanns TF. Dynamic associations between borderline personality disorder and stressful life events over five years in older adults. Personal Disord: Theory Res Treat. 2018;9:521.
doi: 10.1037/per0000281
Baldwin JR, Degli Esposti M. Triangulating evidence on the role of perceived versus objective experiences of childhood adversity in psychopathology. JCPP Adv. 2021;1:e12010.
doi: 10.1111/jcv2.12010
Sansone RA, Sansone LA. Gender patterns in borderline personality disorder. Innov Clin Neurosci. 2011;8:16.
pubmed: 21686143
pmcid: 3115767
Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69:533.
pubmed: 18426259
pmcid: 2676679
doi: 10.4088/JCP.v69n0404
Barnow S, Herpertz SC, Spitzer C, Stopsack M, Preuss UW, Grabe HJ, et al. Temperament and character in patients with borderline personality disorder taking gender and comorbidity into account. Psychopathology. 2007;40:369–78.
pubmed: 17652949
doi: 10.1159/000106467
Robinson EB, Lichtenstein P, Anckarsäter H, Happé F, Ronald A. Examining and interpreting the female protective effect against autistic behavior. Proc Natl Acad Sci. 2013;110:5258–62.
pubmed: 23431162
pmcid: 3612665
doi: 10.1073/pnas.1211070110
Källén B, Källén K. The Swedish Medical Birth Register—a summary of content and quality. 2003.
Careja R, Bevelander P. Using population registers for migration and integration research: examples from Denmark and Sweden. Comp Migr Stud. 2018;6:19.
pubmed: 29974034
pmcid: 6004360
doi: 10.1186/s40878-018-0076-4
Brooke HL, Talbäck M, Hörnblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32:765–73.
pubmed: 28983736
pmcid: 5662659
doi: 10.1007/s10654-017-0316-1
Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim J-L, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
pubmed: 21658213
pmcid: 3142234
doi: 10.1186/1471-2458-11-450
Ludvigsson JF, Svedberg P, Olén O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;344:1–15.
Tampe U, Frank S, Weiss RJ, Jansson K-Å. Diagnosis of open tibial fracture showed high positive predictive value in the Swedish National Patient Register. Clin Epidemiol. 2020;12:1113.
pubmed: 33116904
pmcid: 7569172
doi: 10.2147/CLEP.S271173
Kouppis E, Ekselius L. Validity of the personality disorder diagnosis in the Swedish National Patient Register. Acta Psychiatr Scand. 2020;141:432–8.
pubmed: 32092153
doi: 10.1111/acps.13166
Kuja-Halkola R, Juto KL, Skoglund C, Rück C, Mataix-Cols D, Pérez-Vigil A, et al. Do borderline personality disorder and attention-deficit/hyperactivity disorder co-aggregate in families? A population-based study of 2 million Swedes. Mol Psychiatry. 2018:261:1–9.
Bhaskaran K, Rachet B, Evans S, Smeeth L. Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Beta-Blockers and Prostate Cancer Survival-Interpretation of Competing Risks Models. Eur Urol. 2022;64:e86–e87. https://doi.org/10.1016/j.eururo.2013.01.007 .
doi: 10.1016/j.eururo.2013.01.007
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc: Ser B (Methodol). 1995;57:289–300.
Therneau T. A package for survival analysis in R. R package version 3.2-3. Computer software] Rochester, MN: Mayo Clinic. https://CRAN.R-project.org/package=survival . 2020.
Slotema CW, Daalman K, Blom JD, Diederen KM, Hoek HW, Sommer I. Auditory verbal hallucinations in patients with borderline personality disorder are similar to those in schizophrenia. Psychological Med. 2012;42:1873.
doi: 10.1017/S0033291712000165
Strålin P, Hetta J. First episode psychosis: register-based study of comorbid psychiatric disorders and medications before and after. Eur Arch Psychiatry Clin Neurosci. 2020;271:303–13.
pubmed: 32458108
pmcid: 7960599
doi: 10.1007/s00406-020-01139-6
Momen NC, Plana-Ripoll O, Agerbo E, Benros ME, Børglum AD, Christensen MK, et al. Association between mental disorders and subsequent medical conditions. N Engl J Med. 2020;382:1721–31.
pubmed: 32348643
pmcid: 7261506
doi: 10.1056/NEJMoa1915784
Lanska DJ. The Klüver-Bucy syndrome. Neurologic-psychiatric syndromes in focus—Part I. 41. Karger Publishers; 2018. p. 77–89.
Weaver TL, Clum GA. Early family environments and traumatic experiences associated with borderline personality disorder. J Consulting Clin Psychol. 1993;61:1068.
doi: 10.1037/0022-006X.61.6.1068
Cohen P, Chen H, Gordon K, Johnson J, Brook J, Kasen S. Socioeconomic background and the developmental course of schizotypal and borderline personality disorder symptoms. Dev Psychopathol. 2008;20:633–50.
pubmed: 18423098
doi: 10.1017/S095457940800031X
Amstadter AB, Aggen SH, Knudsen GP, Reichborn-Kjennerud T, Kendler KS. Potentially traumatic event exposure, posttraumatic stress disorder, and Axis I and II comorbidity in a population-based study of Norwegian young adults. Soc Psychiatry Psychiatr Epidemiol. 2013;48:215–23.
pubmed: 22782308
doi: 10.1007/s00127-012-0537-2
White CN, Conway CC, Oltmanns TF. Stress and personality disorders. The Oxford handbook of stress and mental health 2019:183.
Neale MC, Røysamb E, Jacobson K. Multivariate genetic analysis of sex limitation and G × E interaction. Twin Res Hum Genet. 2006;9:481–9.
pubmed: 16899154
pmcid: 4246510
doi: 10.1375/183242706778024937
Hall K, Moran P. Borderline personality disorder: an update for neurologists. Pract Neurol. 2019;19:483–91.
pubmed: 31249066
doi: 10.1136/practneurol-2019-002292
Temes CM, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Deaths by suicide and other causes among patients with borderline personality disorder and personality-disordered comparison subjects over 24 years of prospective follow-up. J Clin Psychiatry. 2019;80:0–0.
doi: 10.4088/JCP.18m12436
Caspi A, Houts RM, Belsky DW, Goldman-Mellor SJ, Harrington H, Israel S, et al. The p factor: one general psychopathology factor in the structure of psychiatric disorders? Clin Psychol Sci. 2014;2:119–37.
pubmed: 25360393
pmcid: 4209412
doi: 10.1177/2167702613497473
Kjær JN, Biskin R, Vestergaard C, Munk-Jørgensen P. All-cause mortality of hospital-treated borderline personality disorder: a nationwide cohort study. J Personal Disord. 2020;34:723–35.
doi: 10.1521/pedi_2018_32_403
Healthcare Management Forum. Mental illness-related stigma in healthcare: barriers to access and care and evidence-based solutions. Healthc Manage Forum 2017. SAGE Publications Sage CA: Los Angeles, CA.
Knaak S, Szeto AC, Fitch K, Modgill G, Patten S. Stigma towards borderline personality disorder: effectiveness and generalizability of an anti-stigma program for healthcare providers using a pre-post randomized design. Borderline Personal Disord Emot Dysregul. 2015;2:1–8.